IntegraGen announced unaudited revenue results for the full year 2022. The 2022 unaudited revenue amount to EUR 12,592,000 in 2022, representing an increase of 16% compared to 2021. This growth in all activities reflects the firmness of the company's positioning, both in terms of its main sequencing activities for R&D customers and its expertise in operating platforms on behalf of third parties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.66 EUR | -4.35% | -9.59% | -26.17% |
05-01 | IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-26.17% | 4.94M | |
-27.90% | 9.96B | |
-4.81% | 3.03B | |
+31.37% | 3B | |
-14.73% | 2.18B | |
-14.39% | 1.76B | |
+70.99% | 1.42B | |
+23.17% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |
- Stock Market
- Equities
- ALINT Stock
- News IntegraGen
- IntegraGen Announces Unaudited Revenue Results for the Full Year 2022